AGFB Agfa-Gevaert NV

Agfa-Gevaert: Share buyback program – regulated information

Agfa-Gevaert: Share buyback program – regulated information

Mortsel, Belgium – May 31, 2021 – 5:40 p.m. CET

Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brussels.

The authorization to acquire own shares was granted to the Board of Directors by the Extraordinary General Meeting of Shareholders of May 12, 2020.

Agfa-Gevaert NV has requested a financial intermediary to repurchase

Agfa-Gevaert shares for a maximum amount of 50,000,000 Euro on its behalf under the terms of an initial discretionary mandate agreement with validity until March 31, 2022, effective as from April 1, 2021.

On May 28, 2021, the Agfa-Gevaert Group held 1,347,282 own shares, which represents 0.80% of the total number of shares of the Group.

Detailed operations per day:

DateNumber of sharesAverage price (€)Minimum price (€)Maximum price (€)Total price (€)
      
May 24, 2021   9,5413.80573.79003.8150  36,310.48
May 25, 2021 35,2123.77333.74003.7950132,865.44
May 26, 2021 21,5003.81013.77003.8400 81,917.15
May 27, 2021 23,6743.81563.79503.830090,330.51
May 28, 2021 43,9083.86203.79003.9000169,572.70
      
Total133,8353.8181  510,995.98

About Agfa

The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds four divisions: Radiology Solutions, HealthCare IT, Digital Print & Chemicals and Offset Solutions. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2020, the Group realized a turnover of 1,709 million Euro.

Contact:

Viviane Dictus

Director Corporate Communication

T +32 (0) 3 444 71 24

E

Johan Jacobs

Corporate Press Relations Manager

T +32 (0)3/444 80 15

E

Attachment



EN
31/05/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agfa-Gevaert NV

 PRESS RELEASE

Settlement agreement and payment related to the sale of the Offset Sol...

Settlement agreement and payment related to the sale of the Offset Solutions division                                         March 31, 2026 – 5.40 PM CET Regulated information Settlement agreement and payment related to the sale of the Offset Solutions division Mortsel, Belgium – March 31, 2026 – 5.40 PM CET The Agfa-Gevaert Group today announced that it has entered into a settlement agreement in relation to the purchase price adjustment and certain other outstanding claims arising from the sale of Agfa’s Offset Solutions division entered into in 2022. In January 2026, the independent...

 PRESS RELEASE

Dading en betaling in verband met de verkoop van de divisie Offset Sol...

Dading en betaling in verband met de verkoop van de divisie Offset Solutions 31 maart 2026 – 17u40 CET Gereglementeerde informatie Dading en betaling in verband met de verkoop van de divisie Offset Solutions Mortsel, België – 31 maart 2026 – 17u40 CET De Agfa-Gevaert Groep heeft vandaag bekendgemaakt dat zij een dading heeft gesloten met betrekking tot de aanpassing van de aankoopprijs en bepaalde andere uitstaande vorderingen in verband met de verkoop van Agfa’s divisie Offset Solutions in 2022. In januari 2026 bracht de onafhankelijke expert het eindrapport uit, waarin een prijsaanp...

Guy Sips ... (+4)
  • Guy Sips
  • Jacob Mekhael
  • Mathijs Geerts Danau
  • Wim Lewi
Guy Sips
  • Guy Sips

Agfa Model update after strong 4Q25 recovery, but structural headwinds...

We updated our model (€ 1.0 Target Price maintained) after Agfa delivered a clearly improved 4Q25, with adj. EBITDA up 28% y/y to € 39m and FCF of € 44m, bringing FY25 FCF to a positive € 35m. This late-year rebound partly masks a challenging FY25, which remained dominated by structural pressure in Radiology, the dilutive impact of the ongoing cloud transition in HealthCare IT, and rising uncertainty linked to silver price volatility. Agfa remains confident in the strategic direction of its “Gro...

Guy Sips ... (+6)
  • Guy Sips
  • Jacob Mekhael
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Wim Lewi

ResearchPool Subscriptions

Get the most out of your insights

Get in touch